SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN
SueWallSt, powered by Levi & Korsinsky LLP, issued a solicitation reminding investors of the September 14, 2026 lead plaintiff deadline in a class action against Regeneron Pharmaceuticals. The complaint alleges Regeneron minimized risks regarding the Phase III Fianlimab-Libtayo study, specifically concerning event accrual slowdowns and FDA-related protocol amendments impacting progression-free survival.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.